898746-91-3 Usage
Uses
Used in Pharmaceutical Synthesis:
6-BROMO-4-INDOLE CARBOXYLIC ACID is used as a key intermediate in the synthesis of various pharmaceuticals and organic compounds, leveraging its unique chemical structure to contribute to the development of novel therapeutic agents.
Used in Antibacterial Applications:
6-BROMO-4-INDOLE CARBOXYLIC ACID is used as an antibacterial agent for its potential to combat bacterial infections, providing a valuable resource in the creation of new antimicrobial drugs.
Used in Antifungal Applications:
6-BROMO-4-INDOLE CARBOXYLIC ACID is used as an antifungal agent, harnessing its properties to treat fungal infections, thereby offering a promising avenue for the development of antifungal medications.
Used in Cancer Treatment Research:
6-BROMO-4-INDOLE CARBOXYLIC ACID is used as a subject of research in the treatment of certain types of cancer, with ongoing investigations into its potential therapeutic effects and mechanisms of action in oncology.
Used in Chemical Compound Development:
6-BROMO-4-INDOLE CARBOXYLIC ACID is used as a building block in the development of new chemical compounds, owing to its distinctive molecular structure and functional groups that can be further modified or utilized in various chemical reactions.
Check Digit Verification of cas no
The CAS Registry Mumber 898746-91-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,8,7,4 and 6 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 898746-91:
(8*8)+(7*9)+(6*8)+(5*7)+(4*4)+(3*6)+(2*9)+(1*1)=263
263 % 10 = 3
So 898746-91-3 is a valid CAS Registry Number.
898746-91-3Relevant academic research and scientific papers
Egbert, Jonathan D.,Thomsen, Edwin C.,O'Neill-Slawecki, Stacy A.,Mans, Douglas M.,Leitch, David C.,Edwards, Lee J.,Wade, Charles E.,Weber, Robert S.
, p. 1803 - 1812 (2019)
Electrolysis flow reactors based on the filter-press architecture of redox flow batteries have proven to be effective and scalable toward the production of commercially relevant, pharmaceutical quantities of anilines (>500 kg/year) from halogen-, hydroxyl-, and carbonyl-substituted nitroarenes. Turbulent flow through the carbon felts on which the catalysts were supported facilitated scaling toward production levels because it conferred on the reactors scale-independent, plug flow-like residence time distributions and high mass transfer coefficients. Equipping the cells with microreference electrodes made it possible to transfer reaction conditions first developed in batch systems to the continuous flow reactors. The catalysts prepared by incipient wetness impregnation of metal salts into lightly oxidized carbon felt supports were readily generalizable.
